Optimind Pharma Corp. (CSE:OMND)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
At close: Sep 11, 2025
Optimind Pharma Revenue
Optimind Pharma had revenue of 27.05K CAD in the quarter ending August 31, 2025, a decrease of -34.12%. This brings the company's revenue in the last twelve months to 124.01K, up 11.28% year-over-year. In the fiscal year ending February 28, 2025, Optimind Pharma had annual revenue of 118.37K, down -3.73%.
Revenue (ttm)
124.01K
Revenue Growth
+11.28%
P/S Ratio
4.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
515.74K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 118.37K | -4.59K | -3.73% |
| Feb 29, 2024 | 122.96K | -47.15K | -27.72% |
| Feb 28, 2023 | 170.11K | 70.42K | 70.64% |
| Feb 28, 2022 | 99.69K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition